128 results on '"Le Garff-Tavernier M"'
Search Results
2. Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)
3. Gain in the short arm of chromosome 2 (2p+) induces gene overexpression and drug resistance in chronic lymphocytic leukemia: analysis of the central role of XPO1
4. P11.09.B Chemotherapy is an efficient treatment in primary CNS MALT lymphoma
5. Neurolymphomatosis related to direct epineural invasion of the superficial peroneal nerve from subcutaneous B-cell lymphoma
6. Antibody-dependent cellular cytotoxicity of the optimized anti-CD20 monoclonal antibody ublituximab on chronic lymphocytic leukemia cells with the 17p deletion
7. Cerebrospinal fluid interleukin-10 may be a useful biomarker for atypical primary central nervous system lymphoma relapse
8. Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodies
9. Maintien à long terme d’une réponse complète avec maladie résiduelle indétectable après une stratégie de traitement combinant de l’ibrutinib à une immunochimiothérapie ≪ adaptée ≫ chez les patients atteints d’une leucémie lymphoïde chronique non antérieurement traitée
10. Interest of negative minimal residual disease estimated by flow cytofluorometry after allogeneic stem cell transplantation for chronic lymphocytic leukaemia: P725
11. Test fonctionnel de la p53 et corrélation avec la délétion 17p et/ou les mutations de TP53 dans la leucémie lymphoïde chronique. Résultats du protocole ICLL001 BOMP sous l’égide du groupe FILO
12. P14.49 Primary central nervous system lymphoma presenting as dementia: do not forget IL10 in CSF analysis
13. P14.90 Interleukin 6 is a useful marker for pseudotumoral inflammatory CNS lesions suspicious of lymphoma
14. PB1868 B-CELL PROLYMPHOCYTIC LEUKEMIA (B-PLL) AND PROLYMPHOCYTOID MANTLE CELL LYMPHOMA (PMCL) (MORE THAN 55% OF PROLYMPHOCYTES) ARE CLOSED BUT DISTINCT ENTITIES. ON BEHALF GFCH AND FILO GROUPS
15. Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome
16. Biomarqueurs du liquide cérébro-rachidien au cours des neurosarcoïdoses : apports diagnostiques et pronostiques
17. Neurotoxicity in patients with CNS lymphomas treated with CAR‐T cell therapy. A LOC network study.
18. Les nouveaux antiviraux d’action directe sans interféron rétablissent la tolérance immunitaire dans les vascularites cryoglobulinémiques associées au VHC
19. The optimized anti-CD20 monoclonal antibody ublituximab bypasses natural killer phenotypic features in Waldenstrom macroglobulinemia
20. Marqueurs du LCR et lymphome primitif du système nerveux central
21. Soluble CD23 measurement by CBA: A convenient and reliable quantification method in chronic lymphocytic leukemia
22. Dosage sérique des chaînes légères libres (CLL) d’immunoglobulines dans la recherche d’une immunoglobuline monoclonale. Étude à partir d’un recrutement hospitalier de 135 patients
23. Antibody-dependent cellular cytotoxicity of the optimized anti-CD20 monoclonal antibody ublituximab on chronic lymphocytic leukemia cells with the 17p deletion
24. Utilisation du logiciel Neurosoft ® comme aide à l’interprétation des électrophorèses des protéines sériques
25. Functional assessment of p53 in chronic lymphocytic leukemia
26. Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodies
27. Utilisation du logiciel Neurosoft® comme aide à l’interprétation des électrophorèses des protéines sériques
28. Serum-free light chain elevation is associated with a shorter time to treatment in Waldenstrom's macroglobulinemia
29. Immunophénotypage des hémopathies malignes par cytométrie de flux
30. CAR‐T CELL THERAPY IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): THE EXPERIENCE OF THE FRENCH NETWORK FOR OCULO‐CEREBRAL LYMPHOMAS (LOC)
31. Soluble CD23 measurement by CBA: A convenient and reliable quantification method in chronic lymphocytic leukemia.
32. Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodies.
33. Utilisation du logiciel Neurosoft® comme aide à l’interprétation des électrophorèses des protéines sériques.
34. How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
35. Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process
36. Epilepsy in Patients With Primary CNS Lymphoma: Prevalence, Risk Factors, and Prognostic Significance.
37. [Neurocryptococcosis waiting to be diagnosed].
38. CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network.
39. Prognostic Value of CSF IL-10 at Early Assessment of Induction Chemotherapy in Primary CNS Lymphomas: A LOC Network Study.
40. Progressive multifocal leukoencephalopathy in patients with chronic liver disease successfully treated with pembrolizumab.
41. Circulating tumor cells in Waldenström macroglobulinemia.
42. Analysis of cerebrospinal fluid for the diagnosis of CNS lymphoma: Comparison of the ESCCA/ISCCA protocol and real-world data of the CytHem/LOC French network.
43. Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod.
44. CAR T-cell therapy for central nervous system lymphomas: blood and cerebrospinal fluid biology, and outcomes.
45. A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trial.
46. [Flow cytometry in chronic lymphproliferative disorders: report of a survey on practices on behalf of CytHem].
47. Combining MYD88 L265P mutation detection and clonality determination on CSF cellular and cell-free DNA improves diagnosis of primary CNS lymphoma.
48. Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study.
49. Chemotherapy is an efficient treatment in primary CNS MALT lymphoma.
50. Prevalence of IGLV3-21R110 among familial CLL: a retrospective study of 45 cases.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.